Hep Email Update
Deaths From Chronic Liver Disease on the Rise
Chronic liver disease affects nearly 4.5 million adults in the United States.
Advertisement
Successful Hepatitis C Treatment Improves Liver Cancer Outcomes
People with hepatocellular carcinoma had improved survival after the advent of direct-acting antiviral therapy.
Three-Dose Hepatitis B Vaccine Regimen Protects People With HIV
Nearly all HIV-positive study participants achieved protective antibody levels after two doses of Heplisav-B.
Liver Cancer Risk Falls After Hepatitis C Treatment
However, people with liver cirrhosis remain at risk and should continue screening even after being cured.
CDC Reports Shift in Hepatitis A Infections
Most hepatitis A infections in recent years have been seen in people who use drugs and people experiencing homelessness.
Hep A Outbreaks
Our map outlines where in the United States active cases of hepatitis A have been reported in the past 12 months on a scale from 0 to 100 relative to other states.
Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2022 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.